Strong and increasing evidence shows that nitric oxide (NO) contribute
s to immune function, and in particular to 'non-specific host defense'
. The aim of the present review was to focus the current understanding
of the role of NO as a biochemical effector of L-arginine-dependent c
ell-mediated immune responses to neoplastic cells in vitro and in vivo
. The cytokine-inducible nitric oxide synthase (NOS) seems to mainly b
e implicated in the cytotoxic activity of almost all the effector cell
s involved in tumor cell killing. The cytotoxic actions of NO against
tumor cells appear to be related mainly to inhibition of several heme-
containing enzymes of the mitochondrial electron transport complex and
the citric acid cycle.